Ovid Therapeutics (OVID)
Develops targeted small molecules for neurological disorders involving neuronal hyperexcitability.
$2.56
vs last close−0.21 (−7.43%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 75.38% | 147.22M shares | |
|---|---|---|---|
| 135 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 2.20% | 4.29M shares | |
| 7 holders · as of Jul 8, 2026 | |||
| Other | ≈ 22.42% | 43.79M shares | |
| remainder | |||
195.30M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
135 holders · 147.22M shares · 47 new positions · 82 increased · 27 reduced · 18 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 20.74M | 10.62% | +20.74Mnew | Aug 14, 2026 |
| Eventide Asset Management, LLC | 11.81M | 6.05% | +1.90M | Aug 14, 2026 |
| BlackRock, Inc. | 10.82M | 5.54% | +9.29M | Aug 7, 2026 |
| Ra Capital Management, L.P. | 10.50M | 5.38% | −213.0K | Aug 14, 2026 |
| Affinity Asset Advisors, LLC | 10.14M | 5.19% | −491.8K | Aug 13, 2026 |
| State Street Corp | 7.90M | 4.05% | +7.38M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 7.76M | 3.97% | +2.50M | Aug 13, 2026 |
| Adar1 Capital Management, LLC | 7.42M | 3.80% | +2.87M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | 12.30% | 8.78M | 13G | Dec 9, 2025 |
| Janus Henderson Group PLC | 9.99% | 7.11M | 13G | Dec 8, 2025 |
| Sirenia Capital Management LP | 9.90% | 18.03M | 13G | May 15, 2026 |
| RA Capital Management, L.P. | 9.90% | 13.26M | 13G | Dec 18, 2025 |
| Affinity Asset Advisors, LLC | 9.10% | 15.64M | 13G | May 14, 2026 |
| Eventide Asset Management, LLC | 7.30% | 12.77M | 13G | May 15, 2026 |
| ADAR1 Capital Management, LLC | 6.90% | 9.28M | 13G | Feb 17, 2026 |
| Federated Hermes, Inc. | 5.94% | 7.74M | 13G | Jan 8, 2026 |
| BlackRock, Inc. | 5.80% | 10.82M | 13G | Jul 29, 2026 |
| Balyasny Asset Management L.P. | 5.33% | 7.03M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 23, 2026 | Jeffrey A. Ronaofficer: CBFO | Sale | 8,541 | $1.45 | 88,188 |
| Feb 23, 2026 | Margaret A. Alexanderdirector, officer: President and CEO | Sale | 11,656 | $1.45 | 61,750 |
| Dec 11, 2025 | Jeremy M. Levindirector, officer: CEO | Purchase · 3 lots | 82,904 | $1.40 | 82,904 |
House and Senate disclosures
Not reported.